Skip to main navigation Skip to search Skip to main content

A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies

  • Farhad Islami
  • , Daniel M. Moreira
  • , Paolo Boffetta
  • , Stephen J. Freedland
  • Icahn School of Medicine at Mount Sinai
  • American Cancer Society
  • Tehran University of Medical Sciences
  • Northwell Health System
  • Durham VA Medical Center
  • Duke University

Research output: Contribution to journalReview articlepeer-review

191 Scopus citations

Abstract

Context An association between tobacco smoking and prostate cancer (PCa) incidence and mortality was suggested in an earlier meta-analysis of 24 prospective studies in which dose-response associations and risks per unit of tobacco use were not examined.

Objective We investigated the association between several measures of tobacco use and PCa mortality (primary outcome) and incidence (secondary outcome) including dose-response association. Evidence acquisition Relevant articles from prospective studies were identified by searching the PubMed and Web of Science databases (through January 21, 2014) and reference lists of relevant articles. Combined relative risks (RRs) and 95% confidence intervals (CIs) were calculated using random effects methods. We also calculated population attributable risk (PAR) for smoking and PCa mortality. Evidence synthesis We included 51 articles in this meta-analysis (11 823 PCa deaths, 50 349 incident cases, and 4 082 606 cohort participants). Current cigarette smoking was associated with an increased risk of PCa death (RR: 1.24; 95% CI, 1.18-1.31), with little evidence for heterogeneity and publication bias. The number of cigarettes smoked per day had a dose-response association with PCa mortality (p = 0.02; RR for 20 cigarettes per day: 1.20). The PAR for cigarette smoking and PCa deaths in the United States and Europe were 6.7% and 9.5%, respectively, corresponding to >10 000 deaths/year in these two regions. Current cigarette smoking was inversely associated with incident PCa (RR: 0.90; 95% CI, 0.85-0.96), with high heterogeneity in the results. However, in studies completed in 1995 or earlier (considered as completed before the prostate-specific antigen screening era), ever smoking showed a positive association with incident PCa (RR: 1.06; 95% CI, 1.00-1.12) with little heterogeneity.

Conclusions Combined evidence from observational studies shows a modest but statistically significant association between cigarette smoking and fatal PCa. Smoking appears to be a modifiable risk factor for PCa death.

Patient summary Smoking increases the chance of prostate cancer death. Not smoking prevents this harm and many other tobacco-related diseases.

Original languageEnglish
Pages (from-to)1054-1064
Number of pages11
JournalEuropean Urology
Volume66
Issue number6
DOIs
StatePublished - Dec 1 2014

Keywords

  • Cigarettes
  • Meta-analysis
  • Prospective
  • Prostate cancer
  • Smoking

Fingerprint

Dive into the research topics of 'A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies'. Together they form a unique fingerprint.

Cite this